share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4：持股變動聲明-董事 Borgeson Blake
美股SEC公告 ·  08/09 05:25
牛牛AI助理已提取核心訊息
On August 6, 2024, Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of the company's Class A Common Stock. The transaction was executed on the open market at a price of $6.8213 per share, resulting in a total sale value of approximately $78,083.42. Following the sale, Borgeson directly holds a total of 7,144,216 shares in the company. The sale reflects a direct ownership transaction and is part of Borgeson's regular stock trading activities.
On August 6, 2024, Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of the company's Class A Common Stock. The transaction was executed on the open market at a price of $6.8213 per share, resulting in a total sale value of approximately $78,083.42. Following the sale, Borgeson directly holds a total of 7,144,216 shares in the company. The sale reflects a direct ownership transaction and is part of Borgeson's regular stock trading activities.
2024年8月6日，與Recursion Pharmaceuticals，Inc. [RXRX]有關的Blake Borgeson以每股6.8213美元的價格在公開市場上完成了銷售公司甲類普通股的11,447股。這筆交易的總銷售價值約爲$78,083.42。銷售後，Borgeson在公司持有7144216股，這次銷售反映了他的直接擁有權，並且是Borgeson定期進行股票交易活動的一部分。
2024年8月6日，與Recursion Pharmaceuticals，Inc. [RXRX]有關的Blake Borgeson以每股6.8213美元的價格在公開市場上完成了銷售公司甲類普通股的11,447股。這筆交易的總銷售價值約爲$78,083.42。銷售後，Borgeson在公司持有7144216股，這次銷售反映了他的直接擁有權，並且是Borgeson定期進行股票交易活動的一部分。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。